Why biological weapons risks complicate provision of COVID aid to North Korea
The pandemic has accentuated a dilemma over how to balance humanitarian and military priorities
North Korea is one of 183 countries that have become state parties to the Biological Weapons Convention (BWC), a worldwide agreement that acknowledges the long-lasting and widespread damage biological and toxin weapons are capable of unleashing.
Yet, as the BWC marks its 50-year anniversary in 2022, there are lingering concerns that the DPRK has violated its commitment made on March 13, 1987 to “prohibit the development, production, acquisition, transfer, stockpiling and use of biological and toxin weapons.”
To date, there has not been sufficient public evidence available to substantiate claims of North Korean violations, in part because the nature
- 01Why Biden and Yoon’s vow to bolster deterrence won’t alter North Korea’s course
- 02North Korea’s fertilizer imports remain unusually low ahead of planting seasons
- 03State media review: North Korea’s propaganda war against COVID-19
- 04Four major trends revealed by North Korea’s COVID-19 case numbers
- 05Streets empty but construction, farming active in COVID-hit North Korea: Imagery
- 06What North Korea will and will not do to fight the COVID-19 outbreak
- 07New leader means new uncertainties and nuclear dangers on Korean Peninsula
- 08East Asia is changing. So should the way Washington, Seoul and Tokyo cooperate.